What Are This Month's Legal Developments?

This month saw two major legal developments for the baby food and infant formula industries.

Happening within a week of each other, California Attorney General Rob Bonta issued an enforcement advisory to manufacturers and retailers of baby food sold in California, and Congresswoman Rosa DeLauro (D-CT3) introduced the Infant Formula Safety Modernization Act, which she said would "modernize federal oversight of the nation's infant formula supply and close longstanding gaps in testing, transparency, and regulatory enforcement."

Audience 3rd Novel Ingredients for Infant Formula & Nutrition Summit Speaker

What the Act Would Require:

FDA‑Mandated Pathogen Testing

FDA would be directed to create an official list of microorganisms and pathogens that manufacturers must test for.

Standardized Environmental Monitoring

All infant formula facilities would follow FDA‑defined standards for environmental testing.

Uniform Testing Frequency

The bill specifies how often environmental testing must occur, ensuring consistency across all manufacturers.

Mandatory Reporting

Manufacturers would be required to notify FDA of any positive pathogen test — even if the product is still inside the facility and has not entered the marketplace.

What Are Your Thoughts on This Bill?

While this bill has so far received little media attention, it is important to keep track of any updates that might affect infant formula producers, ingredient suppliers, and partners throughout the early‑life nutrition ecosystem.

Attendees watching speakers 3rd Novel Ingredients for Infant Formula & Nutrition Summit

Explore the Agenda

Discover forward-looking sessions on novel bioactives, clinical validation strategies, global regulatory pathways, formulation challenges, and commercial scale-up shaping the future of infant nutrition 

Networking image 3rd Novel Ingredients for Infant Formula & Nutrition Summit

Partner With Us

Connect with senior R&D, regulatory, and commercial leaders across ingredient providers, formula manufacturers, and foodtech companies seeking innovative, evidence-backed solutions to accelerate safe market entry 

Networking break 3rd Novel Ingredients for Infant Formula & Nutrition Summit

Join Industry Leaders

Network with decision-makers and innovators defining the next generation of clinically validated regulatory-ready ingredients designed to narrow the gap between formula and human breast milk